Tenax Therapeutics (TENX) traded down -2.27 % during a 24 hours period ending at 02:38 AM Central Europe on Tuesday 27th. One Tenax Therapeutics stock can currently be bought for about USD 1.64 on popular exchanges. Current supply of Tenax Therapeutics stocks is 37.4 mn. Tenax Therapeutics has a current market capitalization of USD 64.4 mn and approximately USD 1.5 mn worth of Tenax Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Tenax Therapeutics has traded -8.99 % down. Simple moving average of last 200 days is at USD 10.4. The highest price of past 52 weeks was recorded at USD 19.4 on 07/09/2026. 52 weeks low was at USD 1.31 on 08/10/2026.

Here is how related stocks have performed in the past 24 hours:

  • Greenland Mines (GRML) traded down -3.34 % and now trades at USD 5.79. Greenland Mines has a market capitalisation of USD 77.2 mn.

  • Innovate (VATE) traded down -0.18 % and now trades at USD 5.64. Innovate has a market capitalisation of USD 76.4 mn.

  • Blueport Acquisition Lt (BPAC) traded up 0.1 % and now trades at USD 10.22. Current market capitalisation for Blueport Acquisition Lt is USD 75.6 mn. Blueport Acquisition Lt has a current price to earnings ratio of 204.29.

  • Hyperfine (HYPR) traded down -0.28 % and now trades at USD 0.72. Hyperfine has a market capitalisation of USD 76.8 mn.

  • Outset Medical (OM) traded down -1.68 % and now trades at USD 4.08. Outset Medical has a market capitalisation of USD 77.1 mn.

About Tenax Therapeutics

Tenax Therapeutics, Inc. is a specialty pharmacutical company operating in the Health Care sector with a focus on Biotechnology. The company is located in Morrisville, United States. Their mission is to develop and commerzialize products for the critical care market, with a particular emphasis on treatments for Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFPf). To that end, Tenax Therapeutics uses levosimendan as an active ingredient in their product development. You can find more information about the company and their offerings on their website, www.tenaxthera.com , as well as through their NASDAQ stock exchange.